Clinical Trial Update: Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating avelumab with or without entinostat in advanced epithelial ovarian cancer and peritoneal cancer has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Peritoneal Cancer

Drugs mentioned

• Avelumab (avelumab)
• Entinostat (entinostat)

Snippet

Sponsor: Syndax Pharmaceuticals | Conditions: Epithelial Ovarian Cancer, Peritoneal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-01-10